BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3284911)

  • 1. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.
    Goldberg AL; Kettelhut IC; Furuno K; Fagan JM; Baracos V
    J Clin Invest; 1988 May; 81(5):1378-83. PubMed ID: 3284911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.
    Kettelhut IC; Goldberg AL
    J Clin Invest; 1988 May; 81(5):1384-9. PubMed ID: 3163348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.
    Baracos V; Rodemann HP; Dinarello CA; Goldberg AL
    N Engl J Med; 1983 Mar; 308(10):553-8. PubMed ID: 6402699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of protein degradation in muscle by prostaglandins, Ca2+, and leukocytic pyrogen (interleukin 1).
    Goldberg AL; Baracos V; Rodemann P; Waxman L; Dinarello C
    Fed Proc; 1984 Apr; 43(5):1301-6. PubMed ID: 6323220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes.
    Dinarello CA; Clowes GH; Gordon AH; Saravis CA; Wolff SM
    J Immunol; 1984 Sep; 133(3):1332-8. PubMed ID: 6611371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
    Pang L; Knox AJ
    Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocyte or recombinant interleukin 1's are specific for the secretion of a metalloproteinase from chondrocytes.
    Schnyder J; Payne T; Dinarello CA
    J Immunol; 1987 Jan; 138(2):496-503. PubMed ID: 3098847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle.
    Moldawer LL; Svaninger G; Gelin J; Lundholm KG
    Am J Physiol; 1987 Dec; 253(6 Pt 1):C766-73. PubMed ID: 3501247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
    Seckinger P; Williamson K; Balavoine JF; Mach B; Mazzei G; Shaw A; Dayer JM
    J Immunol; 1987 Sep; 139(5):1541-5. PubMed ID: 3040855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human IL-1 alpha derivative which lacks prostaglandin E2 inducing activity and inhibits the activity of IL-1 through receptor competition.
    Yamayoshi M; Ohue M; Kawashima H; Kotani H; IIda M; Kawata S; Yamada M
    Lymphokine Res; 1990; 9(3):405-13. PubMed ID: 2169012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
    Castor CW; Smith EM; Bignall MC; Hossler PA
    J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 beta production in the rabbit brain during endotoxin-induced fever.
    Nakamori T; Morimoto A; Yamaguchi K; Watanabe T; Murakami N
    J Physiol; 1994 Apr; 476(1):177-86. PubMed ID: 8046632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins.
    Taupin V; Gogusev J; Descamps-Latscha B; Zavala F
    Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
    Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
    Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissimilarities between purified human interleukin-1 and recombinant human interleukin-2 in the induction of fever, brain prostaglandin, and acute-phase protein synthesis.
    Mier JW; Souza LM; Allegretta M; Boone T; Bernheim HA; Dinarello CA
    J Biol Response Mod; 1985 Feb; 4(1):35-45. PubMed ID: 3872345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of B cell tolerance by macrophage-derived mediators: antagonistic effects of prostaglandin E2 and interleukin 1.
    Goldings EA
    J Immunol; 1986 Feb; 136(3):817-22. PubMed ID: 2416834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.